IL-17 promotes the survival and proliferation of FLS in RA patients [6, 29] and in turn, FLS are able to control the pathogenicity of Th17 by modulating IL-17R and IL-23 expression [6, 29]. Here, IL17RA is linked to rheumatoid arthritis.